(Q41469637)

1 October 2017

1 reference

title

Cytokines, molecular biological abnormalities, and acute myelogenous leukemia (English)

1 reference

1 October 2017

author

Parameswaran Venugopal

0 references

author name string

Preisler HD

1

1 reference

1 October 2017

Bi S

2

1 reference

1 October 2017

Venugopal P

3

1 reference

1 October 2017

Raza A

4

1 reference

1 October 2017

publication date

1 April 1997

1 reference

1 October 2017

1 reference

1 October 2017

volume

21

1 reference

1 October 2017

issue

4

1 reference

1 October 2017

page(s)

299-312

1 reference

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Response to treatment in acute non-lymphatic leukaemia: prognostic value of colony forming and colony stimulating capacities of bone marrow and blood cells compared to other parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Parallel studies of clonogenic leukaemia cells and the leukaemia cell population as a whole in acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Some reasons for the lack of progress in the treatment of acute myelogenous leukemia: a review of three consecutive trials of the treatment of poor prognosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Regrowth resistance in leukemia and lymphoma: the need for a new system to classify treatment failure and for new approaches to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Interleukin-1 is one factor which regulates autocrine production of GM-CSF by the blast cells of acute myeloblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Autocrine growth factors and leukaemic haemopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Interleukin-6 production by the blast cells of acute myeloblastic leukemia: regulation by endogenous interleukin-1 and biological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

The expression of FMS, KIT and FLT3 in hematopoietic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Cytokine modulation of interleukin 1 and tumour necrosis factor-alpha secretion from acute myelogenous leukaemia blast cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Cell cycle control and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

The Ras signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Expression of ras oncogenes in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokine genes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

The Relationship of the in vivo Cell Cycle Characteristics and Treatment Outcome in Acute Myelogenous Leukemia to the Expression of the FMS and MYC Proto-Oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Studies of the proliferation and differentiation of immature myeloid cells in vitro: 4: Preculture proto-oncogene expression and the behaviour of myeloid leukemia cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

FMS mutations in patients following cytotoxic therapy for lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

A hypothesis regarding the development of acute myeloid leukemia from preleukemic disorders. The role of protooncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

A factor encoded by 7q31 suppresses expansion of the 7q- clone and delays cytogenetic progression

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Possible co-existence of RAS activation and monosomy 7 in the leukaemic transformation of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

c-myc and c-myb expression in acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

Modulation of acute myeloblastic leukemia (AML) cell proliferation and blast colony formation by antisense oligomer for IL-1 beta converting enzyme (ICE) and IL-1 receptor antagonist (IL-1ra)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900097-5

7 January 2021

10.1016/S0145-2126(96)00097-5

Identifiers

DOI

1 reference

1 October 2017

1 reference